7-LB: Lowering of Blood Pressure and Pulse Rate by Switching from DPP-4 Inhibitor to Luseogliflozin in Patients with Type 2 Diabetes and Hypertension: A Multicenter, Prospective, Randomized, Open-Label, Parallel-Group Comparison Trial
HASHIMOTO-KAMEDA, REINA, CHO, KYUYONG, NOMOTO, HIROSHI, NAKAMURA, AKINOBU, OMORI, KAZUNO, KAWATA, SHINICHIRO, KAMEDA, HIRAKU, ATSUMI, TATSUYA, MIYOSHI, HIDEAKI
Published in Diabetes (New York, N.Y.) (01.06.2021)
Published in Diabetes (New York, N.Y.) (01.06.2021)
Get full text
Journal Article
Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study)
Hashimoto-Kameda, Reina, Cho, Kyu Yong, Nomoto, Hiroshi, Nakamura, Akinobu, Omori, Kazuno, Nagai, So, Edagawa, Sachiko, Kawata, Shinichiro, Takeuchi, Jun, Kameda, Hiraku, Kurihara, Yoshio, Aoki, Shin, Atsumi, Tatsuya, Miyoshi, Hideaki
Published in Diabetes research and clinical practice (01.10.2021)
Published in Diabetes research and clinical practice (01.10.2021)
Get full text
Journal Article